This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rose 5.8% to $6.79 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.6% to 17,754.09 and the Dow Jones Industrial Average rising 1.7% to 41,488.19.
Corbus Pharmaceuticals Holdings Inc. closed 89.0% short of its 52-week high of $61.90, which the company achieved on July 31st.
The stock outperformed some of its competitors, as Vanda Pharmaceuticals Inc. rose 1.2% to $4.98, Fortress Biotech Inc. rose 3.1% to $1.67, and Viking Therapeutics Inc. rose 3.90% to $30.89.
Trading volume totaled 135,971, compared to the 50-day average of 244,556.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 14, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。